Lanraplenib

Lanraplenib is a highly selective and orally active SYK inhibitor (IC50=9.5 nM) in development for the treatment of inflammatory diseases.

1800046-95-0

≥ 2 years

>98% (HPLC)

443.5

C23H25N9O

Research use only, not for human use.

SYK

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

sc-293468 100 µg/mL

Ask

MBS7129558-01 0.05 mL

Ask

MBS7129558-02 0.1 mL

Ask

MBS7129558-03 5x 0.1 mL

Ask

177135-01 48 Tests

Ask

177135-02 96 Tests

Ask